Balance Measures During Stance and Gait: Comparison of Gyroscopic Measurements of Trunk Sway
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Jul 27, 2015
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new device called Sensoro, which is an extended version of Valedo®Motion. The goal is to see if Sensoro can measure trunk sway—how much your upper body moves when you're standing or walking—in the same way that a well-known system called SwayStar does. SwayStar is trusted for accurately measuring balance control, and researchers want to find out if Sensoro can provide similar results.
To be eligible for this study, participants should be healthy adults aged between 65 to 74 years or 29 to 219 years old, and they should not have any reported balance problems. This will be checked by seeing if they can stand on one leg with their eyes closed for at least 14 seconds. However, people with orthopedic issues or diseases that affect balance may not qualify. If you join the trial, you can expect to help researchers understand how well the Sensoro device works compared to the SwayStar system, contributing to better balance assessment tools in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • self reported lack of balance problems (checked by the ability to stand on 1 leg, eyes closed, for at least 14 secs).
- Exclusion Criteria:
- • orthopaedic problems
- • presence of diseases which cause balance problems.
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
John HJ Allum, DSc
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials